✦ LIBER ✦

Bleeding After Percutaneous Coronary Intervention With Bivalirudin or Unfractionated Heparin and One-Year Mortality

✍ Scribed by Gjin Ndrepepa; Stefanie Schulz; Dritan Keta; Julinda Mehilli; Anette Birkmeier; Steffen Massberg; Karl-Ludwig Laugwitz; Franz-Josef Neumann; Melchior Seyfarth; Peter B. Berger; Albert Schömig; Adnan Kastrati

Book ID: 113446778
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 438 KB
Volume: 105
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2009.08.668

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Patient Outcomes with Biva

Comparison of Patient Outcomes with Bivalirudin versus Unfractionated Heparin in Percutaneous Coronary Intervention

✍ Dr. Kristin Watson; Dr. Amy L. Seybert; Ms. Melissa I. Saul; Dr. Joon Sup Lee; D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Effect of bivalirudin on length of stay

Effect of bivalirudin on length of stay in the recovery area after percutaneous coronary intervention compared with heparin alone, heparin + abciximab, or heparin + eptifibatide

✍ Jeffrey M. Schussler; Craig S. Cameron; Azam Anwar; Michael S. Donsky; Kenneth B 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Effect of bivalirudin compared with unfr

Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: The horizons-AMI CMRI substudy

✍ Jochen Wöhrle; Nico Merkle; Markus Kunze; Ecaterina Cristea; Roxana Mehran; Wolf 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

Outcome of urgent and elective percutane

Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin [UFH], enoxaparin or abciximab

✍ C.L Dubois; A Belmans; C.B Granger 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Bleeding Risk and Outcomes of Bivalirudi

Bleeding Risk and Outcomes of Bivalirudin Versus Glycoprotein IIb/IIIa Inhibitors With Targeted Low-Dose Unfractionated Heparin in Patients Having Percutaneous Coronary Intervention for Either Stable or Unstable Angina Pectoris

✍ Daniel H. Steinberg; Palak Shah; Tim Kinnaird; Tina L. Pinto Slottow; Probal K. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Comparison of Bivalirudin and Unfraction

Comparison of Bivalirudin and Unfractionated Heparin Plus Protamine in Patients With Coronary Heart Disease Undergoing Percutaneous Coronary Intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] Trial)

✍ Guido Parodi; Angela Migliorini; Renato Valenti; Benedetta Bellandi; Umberto Sig 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 358 KB